Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Eastern Cooperative Oncology Group
Fred Hutchinson Cancer Center
Yale University
Roswell Park Cancer Institute
National Cancer Institute (NCI)